(Q34567633)

English

Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 August 2017

Low dose treatment with the synthetic cannabinoid Nabilone significantly reduces spasticity-related pain : a double-blind placebo-controlled cross-over trial (English)

1 reference

Europe PubMed Central

3 August 2017

0 references

0 references

6

object named as

Werner Poewe

1 reference

Europe PubMed Central

3 August 2017

author name string

Jörg Wissel

1

1 reference

Europe PubMed Central

3 August 2017

Tanja Haydn

2

1 reference

Europe PubMed Central

3 August 2017

Jörg Müller

3

1 reference

Europe PubMed Central

3 August 2017

Christian Brenneis

4

1 reference

Europe PubMed Central

3 August 2017

Thomas Berger

5

1 reference

Europe PubMed Central

3 August 2017

Ludwig D Schelosky

7

1 reference

Europe PubMed Central

3 August 2017

publication date

20 September 2006

1 reference

Europe PubMed Central

3 August 2017

number of pages

5

1 reference

based on heuristic

inferred from page(s)

Journal of Neurology

1 reference

Europe PubMed Central

3 August 2017

253

1 reference

Europe PubMed Central

3 August 2017

10

1 reference

Europe PubMed Central

3 August 2017

1337-1341

1 reference

Europe PubMed Central

3 August 2017

https://scigraph.springernature.com/pub.10.1007/s00415-006-0218-8

0 references

Anti-emetic efficacy and toxicity of nabilone, a synthetic cannabinoid, in lung cancer chemotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0218-8

21 January 2018

Safety, tolerability, and efficacy of orally administered cannabinoids in MS.

1 reference

https://api.crossref.org/works/10.1007%2FS00415-006-0218-8

21 January 2018

Short-term effects of smoking marijuana on balance in patients with multiple sclerosis and normal volunteers.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the synthetic cannabinoid nabilone on spatial learning and hippocampal neurotransmission.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nabilone. A preliminary review of its pharmacological properties and therapeutic use.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoid receptors and pain

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabis and the brain

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of orally and rectally administered delta 9-tetrahydrocannabinol on spasticity: a pilot study with 2 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Endocannabinoids control spasticity in a multiple sclerosis model

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of nabilone on neuropsychological functions related to driving ability: an extended case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nabilone in the treatment of multiple sclerosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delta-9-tetrahydrocannabinol shows antispastic and analgesic effects in a single case double-blind trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical marijuana and the Supreme Court

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Physiologic disposition of nabilone, a cannabinol derivative, in man

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are oral cannabinoids safe and effective in refractory neuropathic pain?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The therapeutic potential of cannabis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatments for spasticity and pain in multiple sclerosis: a systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Delta-9-THC in the treatment of spasticity associated with multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Analgesic effect of the cannabinoid analogue nabilone is not mediated by opioid receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoids in multiple sclerosis: do they have a therapeutic role?

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of spasticity associated pain with botulinum toxin A.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-spasticity agents for multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Human Spasticity with Δ9-Tetrahydrocannabinol

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic review

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cannabinoids and multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of Spasticity in Spinal Cord Injury with Dronabinol, a Tetrahydrocannabinol Derivative.

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Brain cannabinoid systems as targets for the therapy of neurological disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/16988792

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00415-006-0218-8

1 reference

Europe PubMed Central

3 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

3 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34567633&oldid=1954206354"